September 1, 2014
In adult patients recently diagnosed with type 2 diabetes, a 6-month regimen of metformin appears to have positive effects on body composition, insulin sensitivity and glucose homeostasis, according to recent findings.
In the prospective, non-interventional, observational study, researchers evaluated 51 patients (mean age, 52.67 years) recently diagnosed with type 2 diabetes and started on a metformin regimen. The regimen consisted of 1000 mg metformin, twice daily for 6 months. The researchers evaluated changes in body composition, insulin resistance, insulin sensitivity and metabolic control induced by metformin.